NASDAQ:PBM - Nasdaq - CA74449F1009 - Common Stock - Currency: USD
1.03
-0.21 (-16.94%)
The current stock price of PBM is 1.03 USD. In the past month the price decreased by -34.39%. In the past year, price decreased by -99.35%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 20.9 | 373.71B | ||
AMGN | AMGEN INC | 15.68 | 166.89B | ||
GILD | GILEAD SCIENCES INC | 25.16 | 144.52B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1666.59 | 124.16B | ||
REGN | REGENERON PHARMACEUTICALS | 15.01 | 74.87B | ||
ARGX | ARGENX SE - ADR | 242.26 | 37.83B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.41B | ||
BNTX | BIONTECH SE-ADR | N/A | 26.75B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.20B | ||
BIIB | BIOGEN INC | 8.6 | 20.65B | ||
NTRA | NATERA INC | N/A | 18.89B | ||
GMAB | GENMAB A/S -SP ADR | 24.69 | 14.59B |
Psyence Biomedical Ltd. is a life science biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
PSYENCE BIOMEDICAL LTD
121 Richmond Street West Penthouse, Suite 1300
TORONTO ONTARIO V6E 3Z3 CA
CEO: John Plourde
Employees: 0
Company Website: http://psyence.com
Investor Relations: http://psyence.com/investors/
Phone: 17744604171
The current stock price of PBM is 1.03 USD. The price decreased by -16.94% in the last trading session.
The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.
PBM stock is listed on the Nasdaq exchange.
PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 4.03M USD. This makes PBM a Nano Cap stock.
PSYENCE BIOMEDICAL LTD (PBM) currently has 0 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PBM does not pay a dividend.
The outstanding short interest for PSYENCE BIOMEDICAL LTD (PBM) is 7.71% of its float. Check the ownership tab for more information on the PBM short interest.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |